Identifikasi Interaksi Obat pada Resep dengan Diagnosa Gangguan Sistem Endokrin Periode Bulan Juli 2024 di Rumah Sakit X Kota Bandung

Salma Tri Octaviany; Tina Rostinawati

doi:10.61132/obat.v3i1.1026

Authors

Salma Tri Octaviany Universitas Padjadjaran
Tina Rostinawati Universitas Padjadjaran

DOI:

https://doi.org/10.61132/obat.v3i1.1026

Keywords:

drug interactions, endocrine system, prescriptions

Abstract

Drug interactions can occur when drugs are administered simultaneously with other drugs, both pharmacologically and clinically. This study aims to identify drug interactions that occur in prescriptions with patients experiencing endocrine system disorders for the period July 2024 at Hospital X, Bandung City. Endocrine disorders, involving hormonal dysfunction such as that of the thyroid, adrenals, or pancreas, can affect the pharmacokinetics and pharmacodynamics of drugs, thereby increasing the risk of interactions. This research method involved randomly collecting two prescriptions per day, with a total of 60 recipes analyzed. The results of the assessment showed that there were 15 potential drug interactions with a percentage of 25%, consisting of one minor interaction (6.67%), 15 moderate interactions (93.33%), and no major interactions were found.

Downloads

Download data is not yet available.

References

Alorfi, N.M., Alqurashi, R.S. & Algarni, A.S. 2023. Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia. Frontiers in Pharmacology, 14.

Bommer, C., Sagalova, V., Heesemann, E., Manne-Goehler, J., Atun, R., Bärnighausen, T., Davies, J. & Vollmer, S. 2018. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030. Diabetes Care, 41(5): 963–970.

Chowdhury, K., Hazra, A., Ghosh, S. & Choudhury, S. 2024. Drug use survey to identify significant drug–drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital. Indian Journal of Pharmacology, 56(3): 172–177.

Dai, D., Feinstein, J.A., Morrison, W., Zuppa, A.F. & Feudtner, C. 2016. Epidemiology of Polypharmacy and Potential Drug–Drug Interactions Among Pediatric Patients in ICUs of U.S. Children’s Hospitals*. Pediatric Critical Care Medicine, 17(5): e218–e228.

Drugs.com. 2024. Drug Interaction. https://www.drugs.com/drug_interactions.html.

Fauziah, D.W. & Trisnawati. 2019. GAMBARAN PENGGUNAAN SUKRALFAT PADA PASIEN GASTRITIS RAWAT INAP PENYAKIT DALAM DI RS.HASANUDDIN DAMRAH BENGKULU. Jurnal Penelitian dan Kajian Ilmiah Kesehatan, 5(1).

Koziolek, M., Alcaro, S., Augustijns, P., Basit, A.W., Grimm, M., Hens, B., Hoad, C.L., Jedamzik, P., Madla, C.M., Maliepaard, M., Marciani, L., Maruca, A., Parrott, N., Pávek, P., Porter, C.J.H., Reppas, C., van Riet-Nales, D., Rubbens, J., Statelova, M., Trevaskis, N.L., Valentová, K., Vertzoni, M., Čepo, D.V. & Corsetti, M. 2019. The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group. European Journal of Pharmaceutical Sciences, 134: 31–59.

Kumar, P.P.J. & Clark, M.L. 2009. Kumar and Clark’s Clinical Medicine. Elsevier.

Kumari, Y., Bai, P., Waqar, F., Asif, A.T., Irshad, B., Raj, S., Varagantiwar, V., Kumar, M., Neha, F., Chand, S., Kumar, S., Varrassi, G., Khatri, M. & Mohamad, T. 2023. Advancements in the Management of Endocrine System Disorders and Arrhythmias: A Comprehensive Narrative Review. Cureus.

May, M. & Schindler, C. 2016. Clinically and pharmacologically relevant interactions of antidiabetic drugs. Therapeutic Advances in Endocrinology and Metabolism, 7(2): 69–83.

Medscape. 2024. Drug Interaction Checker. https://reference.medscape.com/drug-interactionchecker.

Morales-Ríos, O., Jasso-Gutiérrez, L., Reyes-López, A., Garduño-Espinosa, J. & Muñoz-Hernández, O. 2018. Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico. PLOS ONE, 13(1): e0190882.

Niza, H., Anwar, S.H.A. & Arimbi, R. 2023. EVALUASI POTENSI TERJADINYA INTERAKSI OBAT PADA PASIEN DIABETES MELITUS TIPE 2 DENGAN PENGGUNAAN OBAT ANTIBIOTIK DI RUMAH SAKIT AR BUNDA PRABUMULIH. JURNAL KESEHATAN TAMBUSAI , 4(4): 6368–6374.

Perhimpunan Nefrologi Indonesia. 2023. KONSENSUS GANGGUAN GINJAL AKUT. Jakarta: PERNEFRI.

Poluan, O.A., Wiyono, W.I. & Yamlean, P.V.Y. 2020. IDENTIFIKASI POTENSI INTERAKSI OBAT PADA PASIEN DIABETES MELITUS TIPE 2 RAWAT INAP DI RUMAH SAKIT GUNUNG MARIA TOMOHON PERIODE JANUARI – MEI 2018. PHARMACON, 9(1): 38.

Rogowicz-Frontczak, A., Majchrzak, A. & Zozulińska-Ziółkiewicz, D. 2017. Insulin resistance in endocrine disorders - treatment options. Endokrynologia Polska, 68(3): 334–351.

Sachmechi, I., Reich, D.M., Aninyei, M., Wibowo, F., Gupta, G. & Kim, P.J. 2007. Effect of Proton Pump Inhibitors on Serum Thyroid-Stimulating Hormone Level in Euthyroid Patients Treated with Levothyroxine for Hypothyroidism. Endocrine Practice, 13(4): 345–349.

Shariff, A., Belagodu Sridhar, S., Abdullah Basha, N., Bin Thaleth Alshemeili, S.S.H. & Ahmed Aljallaf Alzaabi, N.A. 2022. Development and validation of standardized severity rating scale to assess the consistency of drug-drug interaction severity among various drug information resources. Research in Social and Administrative Pharmacy, 18(8): 3323–3328.

Skelin, M., Lucijanić, T., Amidžić Klarić, D., Rešić, A., Bakula, M., Liberati-Čizmek, A.-M., Gharib, H. & Rahelić, D. 2017. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clinical Therapeutics, 39(2): 378–403.

Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J. & Mao, F. 2024. Cell–cell communication: new insights and clinical implications. Signal Transduction and Targeted Therapy, 9(1): 196.

Tavousi, F., Sadeghi, A., Darakhshandeh, A. & Moghaddas, A. 2019. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study. Journal of Pediatric Hematology/Oncology, 41(3): e146–e151.

Utami, P.R. & Octavia, D.R. 2022. Study of potential interactions of oral antidiabetic drugs in patients with type 2 diabetes mellitus with comorbidities: A retrospective study. Pharmacy Education, 22(2): 200–206.

Viera, Y.R., Saavedra, I.A., Rodríguez, R.G., Martín, N.E., Granados, S.F. & Cantón, C.G. 2019. Metformin and diuretics. Nefrología (English Edition), 39(5): 557–558.

Wondm, S.A., Tamene, F.B., Gubae, K., Dagnew, S.B., Worku, A.A. & Belachew, E.A. 2023. Potential drug–drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study. BMJ Open, 13(12): e077863.